Panel Proposes Standards for Reporting Data From Immuno-Oncology Trials

March 6, 2019 – The standards for reporting findings from immunotherapy studies should reflect the unique efficacy and toxicity characteristics of this rapidily emerging modality, with detailed and transparent explanations of definitions, according to a panel of experts. The panel developed 12 recommendations for improving the reporting of data from immunooncology (IO) trials which are detailed in a joint report from the American Society of Clinical Oncology … (leggi tutto)